Discover our leading batch-produced active pharmaceutical ingredients and specialized protected amino acids engineered under rigorous cGMP protocols for global export.
In the rapidly evolving pharmaceutical, biopharmaceutical, and fine chemical landscapes, securing a resilient supply chain of high-grade raw materials is a strategic imperative. As an established OEM Raw Materials Factory & Company, Gentolex bridges the gap between laboratory-scale synthesis and industrial commercialization. Modern drug discovery, therapeutic research, and chemical synthesis demand uncompromised batch-to-batch consistency, complete regulatory filing support (including Drug Master Files and Certificates of Suitability), and adherence to cGMP guidelines.
The international supply ecosystem for active pharmaceutical ingredients (APIs), key starting materials (KSMs), and complex peptide building blocks (such as Fmoc and Boc protected amino acids) faces unprecedented structural shifts. Global enterprises are transitioning from fragmented vendor networks toward integrated OEM CDMO/CMO partnerships. This structural transformation guarantees rigorous purity profiles—frequently exceeding 99.0% by HPLC—while mitigating geopolitical, logistical, and compliance risks across North American, European, LATAM, and African regulatory jurisdictions.
Gentolex’s overarching mission is to create sustainable global connections by delivering superior service frameworks and fully certified chemical solutions. To date, Gentolex Group serves clientele across more than 10 countries, backed by localized technical representation established strategically in Mexico and South Africa. Our core focus spans supplying peptide APIs, custom peptide synthesis, finished dosage form (FDF) licensing out, technical consultation, lab and product line setup, alongside comprehensive supply chain management.
Our state-of-the-art manufacturing campus encompasses an overall factory construction area of 250,000 square meters. Constructed fully to international standards, this infrastructure provides versatile, scalable, and cost-effective batch and continuous chemical synthesis solutions.
Gentolex offers an extensive catalog of APIs and synthetic intermediates for clinical development and large-scale commercial applications. Operating under long-term collaborative cGMP frameworks, complete documentation, regulatory dossiers, and analytical certificates (CoA, HPLC, MS) are seamlessly provided to global clients.
For global partners seeking to minimize administrative complexity, we offer specialized procurement services backed by robust supply chain sourcing. From laboratory setup to regulatory filing and FDF licensing, our end-to-end management mitigates bottleneck risks.
The integration of Industry 4.0 methodologies within Chinese chemical synthesis facilities has fundamentally reshaped high-volume raw material procurement. By merging real-time Manufacturing Execution Systems (MES), automated DCS process controllers, and IoT-enabled environmental monitoring, our 250,000 m² production hub minimizes human error and guarantees batch homogeneity.
Automated reactors monitor precise thermodynamic parameters, pH balances, and stoichiometric dosing during complex peptide chain extensions and organic liquid-phase condensation steps.
In-line FTIR, UV-Vis spectroscopy, and automated HPLC sampling track reaction kinetics dynamically, maximizing yield and preventing impurity formation before downstream crystallization.
Dual manufacturing lines, modular cleanrooms (Class 100,000 to Class 10,000), and automated back-up systems ensure uninterrupted commercial supply chains for international partners.
As synthetic chemistry progresses toward sustainable, high-efficiency paradigms, Gentolex advances next-generation chemical engineering frameworks designed for mid-to-long-term commercial viability.
Implementation of closed-loop solvent reclamation technology, reducing hazardous organic solvent waste (DMF, NMP, DCM) by up to 65% during solid-phase peptide synthesis (SPPS) and large-scale extraction processes.
Transitioning long-chain therapeutic peptide synthesis toward hybrid platforms combining liquid-phase fragment assembly with chemo-enzymatic ligations, significantly lowering protecting group requirements and cost-per-gram.
Pioneering microfluidic flow reactors for highly exothermic reactions (hazardous nitrations, halogenations, and fast-coupling step reactions) to ensure safety, maximum yield, and instant scalability from laboratory to metric-ton outputs.
Global pharmaceutical buyers, formulators, and distributors encounter distinct procurement hurdles: shifting tariff structures, strict quality validation requirements, and unpredictable lead times. Gentolex addresses these critical buyer intents through customized B2B solutions.
We provide tiered pricing and contract scaling from multi-gram R&D batches up to multi-ton commercial production runs, maintaining uncompromised purity standards regardless of order volume.
Strict non-disclosure agreements (NDAs) combined with isolated custom production suites ensure that client proprietary chemical pathways and peptide formulations remain completely protected.
Each batch shipment includes full analytical validation packages: RP-HPLC chromatograms, LC-MS spectra, 1H/13C-NMR data, heavy metal ICP-MS screening, and residual solvent analysis via headspace GC-MS.
Navigating regulatory submissions requires deep regional expertise. Gentolex maintains established direct regional representative offices in Mexico and South Africa, expanding localized sales, technical consultation, customs clearance support, and swift emergency order management.
Facilities and documentation standards align with US FDA cGMP requirements and European Pharmacopoeia (Ph. Eur.) monographs, facilitating smooth filing of Type II DMFs and CEP applications.
Our direct presence in Mexico and South Africa ensures streamlined logistics, localized billing options, real-time customer care, and compliance with local COFEPRIS and SAHPRA regulatory guidelines.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Derived from endogenous tuftsin, Selank is manufactured under strict cGMP protocols...
View Details →
As a dedicated Thymosin Beta-4 API manufacturer and global supplier, we offer batch-tested Tβ4 peptide solutions for biomedical research organizations and therapeutic formulators requiring strict purity specifications...
View Details →
BPC-157 API is a synthetic pentadecapeptide receiving substantial investigation due to its bio-active potential in cellular research and tissue dynamics. Gentolex supplies premium bulk batches under cGMP standards...
View Details →
Derived from ACTH fragments, Semax peptide API continues to be a cornerstone sequence in neuroscience research. Our facility provides reproducible synthesis with complete analytical qualification...
View Details →
SS-31 API (Elamipretide / MTP-131) is a synthetic mitochondria-targeting tetrapeptide designed for cellular bioenergetics research. Commercial quantities are available with complete dossier backing...
View Details →
Explore additional high-demand APIs, amino acid derivatives, and specialized compounds manufactured to rigorous international purity guidelines.
